Vascular access malfunction: towards a more genecentric view

Clin Nephrol. 2013 Nov;80(5):370-6. doi: 10.5414/CN107071.

Abstract

A well-functioning vascular access is the cornerstone for an optimal hemodialysis treatment and an issue of major importance for the outcome of patients on chronic hemodialysis. Over the last few years reports supporting the aspect that mechanisms involved in vascular access malfunction are genetically controlled have been published. Triggered by two cases reported herein, we present a comprehensive review of the literature on an evolving field of particular significance to patients on hemodialysis.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Arteriovenous Shunt, Surgical / adverse effects*
  • Factor V / genetics
  • Heme Oxygenase-1 / genetics
  • Humans
  • Interleukin-10 / genetics
  • Male
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics
  • Middle Aged
  • Peptidyl-Dipeptidase A / genetics
  • Renal Dialysis / adverse effects*
  • Transforming Growth Factor beta1 / genetics

Substances

  • Transforming Growth Factor beta1
  • Interleukin-10
  • Factor V
  • Heme Oxygenase-1
  • Methylenetetrahydrofolate Reductase (NADPH2)
  • Peptidyl-Dipeptidase A